Partner News

Pfizer News Banner

Pfizer Letter to the Duchenne Community

Update on Pfizer’s Duchenne gene therapy Phase 3 clinical program In line with our continued efforts to work with the Duchenne community and share information as it becomes available, we […]

Entrada Industry News Banner

CureDuchenne Invests in Entrada Therapeutics

CureDuchenne continued funding a robust Duchenne drug development pipeline with a new investment in Entrada Therapeutics as part of their latest financing from a group of investors. Entrada Therapeutics’ promising […]